Shanghai MicuRx Pharmaceutical Co., Ltd. Stock: price and insider trades · China
盟科药业
No insider purchase over the last 90 days. The latest, by 金燕, was filed 04 Mar 2026.
Shanghai MicuRx Pharmaceutical Co., Ltd.: what insiders have been doing
Shanghai MicuRx Pharmaceutical Co., Ltd., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SSE / SZSE (CSRC). Over the twelve months to 4 November 2026, 2 filings were filed, from 1 insider.
No insider sold shares on the market over the period. Instead, the filings list 2 purchases totalling €2,215, made by 1 insider. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The buyers include 1 board member. At €1,516, the purchase published on 2 March 2026 by 金燕 is the largest of the period.
Compared with its exchange (517 companies, median 2 filings), a count of 2 filings is typical. Over the whole record (from 2024), the tally stands at 6 purchases and no sales.
The last insider purchase was made public on 4 March 2026, 251 days ago.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and UCB. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- -15.6%Entry CN¥5.65 · Close 03 Nov 2026 CN¥4.77
- +12.1%Entry CN¥5.30 · Close at T+365 CN¥5.94
- -6.7%Entry CN¥5.64 · Close at T+365 CN¥5.26
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 1,000 shares31.5% of flowA股XSHGSSE:273000000231958180Canonical exit: 2 Jun 2026 (T+90)
- 2,000 shares68.5% of flowA股XSHGSSE:273000000231958080Canonical exit: 31 May 2026 (T+90)
- 300,000 shares100.0% of flowA股XSHGSSE:173000007482653980Canonical exit: 10 Jul 2024 (T+90)
- 14,000 shares100.0% of flowA股XSHGSSE:173000007471566800Canonical exit: 7 Jul 2024 (T+90)
- 70,000 shares100.0% of flowA股XSHGSSE:173000007471566820Canonical exit: 7 Jul 2024 (T+90)
- 60,000 shares100.0% of flowA股XSHGSSE:173000007445223680Canonical exit: 27 Jun 2024 (T+90)
6 of 6 declarations
About Shanghai MicuRx Pharmaceutical Co., Ltd.
盟科药业 is a company operating in the health and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and commercialization of innovative drugs.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
